A Novel Immunotype-based Risk Stratification Model Predicts Postoperative Prognosis and Adjuvant TACE Benefit in Chinese Patients with Hepatocellular Carcinoma

Conclusion: A novel immunotype-based risk stratification model was built to predict postoperative prognosis and adjuvant TACE benefit in HCC patients. These tools can assist in building a more customized method of HCC treatment.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Tian-En Li, Ze Zhang, Yi Wang, Da Xu, Jian Dong, Ying Zhu, Zheng Wang Tags: Research Paper Source Type: research